Vincere Biosciences
Developing small molecule therapeutics to protect the body’s most mitochondria-dense organs including the brain, heart, and kidneys by enhancing the cell’s natural ability to clear out damaged mitochondria.
Vincere Biosciences is developing small molecule therapeutics to protect the body’s most mitochondria-dense organs including the brain, heart, and kidneys by enhancing the cell’s natural ability to clear out damaged mitochondria.Built at the intersection of AI-driven discovery and cutting-edge biology, Vincere targets a key driver of age-related decline: dysfunctional mitochondria. With programs advancing toward the clinic, the company is positioned to impact a range of diseases from Parkinson’s disease to cardiorenal conditions - and may more broadly extend healthy human lifespan.
Testimonial
Related Companies
Klona Biotech
The future of human tissue replacements using 3D printing
London, United Kingdom
Lyric Bio
Pioneering the future of biomanufacturing using proven and proprietary 3D bioprinting and tissue engineering technologies
San Carlos, California
Eywa Biotech
Scaling the production of pharmaceutical-grade psychedelic compounds through synthetic biology
Montevideo, Uruguay · Buenos Aires, Argentina
PrettyLitter
Develops a lightweight cat litter that helps cat owners monitor their pets' health by changing colors in response to abnormalities in urine.
Los Angeles, United States
nVision
nVision’s focus is on women’s health. The company created the first FDA-cleared device for collecting cells from the fallopian tubes, which aimed to enable earlier diagnosis of ovarian cancer. In 2018, nVision was acquired by Boston Scientific.
Senodia
MEMS sensors for various applications.
China, Shanghai
Aanika
Innovative science-backed insurance solutions for agriculture and food industries with Bio technology.
Brooklyn, United States
